ise-view-Article Detail Bottom List


Source:Boston Scientific Corporation

Date Published:12/19/2012 02:12:09 PM

Boston Scientific’s WATCHMAN? Left Atrial Appendage (LAA) Closure Device has received the CE Mark for expanded indication. The new indication offers patients with atrial fibrillation (AF), and a contraindication to warfarin and the newer oral anticoagulants, a new treatment option for stroke reduction. The WATCHMAN is a permanent implant designed to capture harmful blood clots, which may cause the stroke. The device is introduced into the heart via a catheter through a vein in the groin, intended to close off the LAA. The device was approved for use in Europe in 2005 and in some Asian countries in 2009. It is currently an investigational device in the US.

Nike Air Jordan 1 Retro


Not interesting to Very interesting
Enter the characters shown in the image.

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.